Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Identification of Novel Antisense-Mediated Exon Skipping Targets in DYSF for Therapeutic Treatment of Dysferlinopathy.

Lee JJA, Maruyama R, Duddy W, Sakurai H, Yokota T.

Mol Ther Nucleic Acids. 2018 Dec 7;13:596-604. doi: 10.1016/j.omtn.2018.10.004. Epub 2018 Oct 11.

2.
3.

Cell Membrane Repair Assay Using a Two-photon Laser Microscope.

Lee JJA, Maruyama R, Sakurai H, Yokota T.

J Vis Exp. 2018 Jan 2;(131). doi: 10.3791/56999.

4.

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy.

Miskew Nichols B, Aoki Y, Kuraoka M, Lee JJ, Takeda S, Yokota T.

J Vis Exp. 2016 May 24;(111). doi: 10.3791/53776.

5.

New developments in exon skipping and splice modulation therapies for neuromuscular diseases.

Touznik A, Lee JJ, Yokota T.

Expert Opin Biol Ther. 2014 Jun;14(6):809-19. doi: 10.1517/14712598.2014.896335. Epub 2014 Mar 12. Review.

PMID:
24620745
6.

Duplicated crabp1 and crabp2 genes in medaka (Oryzias latipes): gene structure, phylogenetic relationship and tissue-specific distribution of transcripts.

Parmar MB, Lee JJ, Wright JM.

Comp Biochem Physiol B Biochem Mol Biol. 2013 May;165(1):10-8. doi: 10.1016/j.cbpb.2013.02.006. Epub 2013 Feb 28.

PMID:
23458901
7.

Antisense therapy in neurology.

Lee JJ, Yokota T.

J Pers Med. 2013 Aug 2;3(3):144-76. doi: 10.3390/jpm3030144. Review.

Supplemental Content

Loading ...
Support Center